Focus: BioStem Technologies is a publicly traded biotechnology company specializing in perinatal tissue products for regenerative therapies, headquartered in Pompano Beach, Florida. The company operates at an early commercialization stage with a small active job base of 14 open positions.
Profile data last refreshed 7h ago · AI intelligence enriched 2mo ago
Stable — net -3 jobs in 30d
2 added, 5 removed. Backfill posture.
BioStem represents a high-risk, early-stage opportunity suitable for entrepreneurial professionals comfortable with execution uncertainty but uncertain commercial viability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for BioStem Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from BioStem Technologies's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference - The Manila Times
BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference The Manila Times
BioStem Technologies Names Mark Glickman, Steven Sonenreich and Rayna Hannaway to Board - citybiz
BioStem Technologies Names Mark Glickman, Steven Sonenreich and Rayna Hannaway to Board citybiz
Hospital chief, biotech exec and investor join BioStem board - Stock Titan
Hospital chief, biotech exec and investor join BioStem board Stock Titan
BioStem Technologies Announces Appointment of Three New Members to its Board of Directors - GlobeNewswire
BioStem Technologies Announces Appointment of Three New Members to its Board of Directors GlobeNewswire
BioStem Technologies expands board with three appointments as Nasdaq uplisting remains a key objective (BSEM) - MSN
BioStem Technologies expands board with three appointments as Nasdaq uplisting remains a key objective (BSEM) MSN
Regenerative medicine company raises $2.5 million ahead of Boca Raton expansion - The Business Journals
Regenerative medicine company raises $2.5 million ahead of Boca Raton expansion The Business Journals
Showing 6 of 10 news items
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo